[PDF][PDF] Drug targets and resistance mechanisms in multiple myeloma
J Nass, T Efferth - Cancer Drug Resist, 2018 - pdfs.semanticscholar.org
Multiple myeloma (MM), a malignancy of plasma cells, is the second most prevalent blood
cancer (10%). A PubMed search has been conducted for English research papers and …
cancer (10%). A PubMed search has been conducted for English research papers and …
[HTML][HTML] Tubulin couples death receptor 5 to regulate apoptosis
Activation of death receptor 5 (DR5) to induce apoptosis in cancer cells is an attractive
strategy for cancer therapy. However, many tumor cell lines and primary tumors are resistant …
strategy for cancer therapy. However, many tumor cell lines and primary tumors are resistant …